PATENT CLAIM ANALYSIS

Application Number: 16357249
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "172100"]

Abstract:
The invention relates generally to the treatment of cancer. One embodiment of the invention provides a method of treating cancer in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).

Claim (Index 10):
The method of  claim 1 , further comprising:\n determining, from a tumor sample obtained from the individual's body, a level of aurora kinase A (AURKA) expression; and in the case that the level of AURKA expression is indicative of overexpression, administering to the individual an effective amount of trichostatin A (TSA).

Metadata:
- Claim Count in Document: 7.0
- Percentile: 99.0
- Lexical Diversity: 1.43333
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15980644', '13167431', '14844270', '14112358', '15996945']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6895810423605669
- 35 USC 102 Novelty (BERT): 0.5042941325187997
- Combined Prediction Score: 0.6710523513763903
- Mean Citation Score: 193.559916
- Max Citation Score: 265.74492999999995
- Similarity Product: 197.3233421662468

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test